Seattle Genetics Announces Clinical Data Presentations from Multiple Antibody-Drug Conjugate Programs
May 28, 2015 at 09:02 AM EDT
Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that data from multiple proprietary and collaborator antibody-drug conjugate (ADC) ...